Robert Paarlberg is the Principal of Paarlberg & Associates LLC, a consultancy specializing in global clinical trial disclosure strategy and operations, regulatory policy and regulatory intelligence. Bob has more than 35 years of pharmaceutical industry experience with the vast majority of his experience in US and international regulatory affairs. Bob has been actively involved with clinical trial disclosure since 2005 where he was responsible for implementing UCB’s clinical trial disclosure processes. Bob is current Chair of DIA’s Clinical Trial Disclosure Community (2013-2016). He received a M.S. in Analytical Chemistry from Purdue University.